Literature DB >> 8497070

Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria.

J Luban1, C Lee, S P Goff.   

Abstract

We have expressed the human immunodeficiency virus type 1 (HIV-1) protease (PR) in bacteria as a Gag-PR polyprotein (J. Luban and S.P. Goff, J. Virol. 65:3203-3212, 1991). The protein displays enzymatic activity, cleaving the Gag polyprotein precursor Pr55gag to the expected products. The PR enzyme is only active as a dimer, and we hypothesized that PR activation might be used as an indicator of polyprotein multimerization. We constructed 25 linker insertion mutations throughout gag and assessed the PR activity of mutant Gag-PR polyproteins by the appearance of Gag cleavage products in bacterial lysates. All mutant constructs produced stable protein in bacteria. PR activity of the majority of the Gag-PR mutants was indistinguishable from that of the wild type. Six mutants, one with an insertion in the matrix (MA), four with insertions in the capsid (CA), and one with insertions in the nucleocapsid (NC), globally disrupted polyprotein processing. When PR was provided in trans on a separate plasmid, the Gag proteins were cleaved with wild-type efficiency. These results suggest that the gag mutations identified as disruptive of polyprotein processing did not conceal the scissile bonds of the polyprotein. Rather, the mutations prevented PR activation in the context of a Gag-PR polyprotein, perhaps by preventing polyprotein dimerization.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8497070      PMCID: PMC237714          DOI: 10.1128/JVI.67.6.3630-3634.1993

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Processing of avian retroviral gag polyprotein precursors is blocked by a mutation at the NC-PR cleavage site.

Authors:  H Burstein; D Bizub; M Kotler; G Schatz; V M Vogt; A M Skalka
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

2.  Form, function, and use of retroviral gag proteins.

Authors:  J W Wills; R C Craven
Journal:  AIDS       Date:  1991-06       Impact factor: 4.177

3.  Characterization of ribosomal frameshifting in HIV-1 gag-pol expression.

Authors:  T Jacks; M D Power; F R Masiarz; P A Luciw; P J Barr; H E Varmus
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

4.  Extracellular creatine regulates creatine transport in rat and human muscle cells.

Authors:  J D Loike; D L Zalutsky; E Kaback; A F Miranda; S C Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

5.  A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.

Authors:  S Crawford; S P Goff
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

6.  Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.

Authors:  C Debouck; J G Gorniak; J E Strickler; T D Meek; B W Metcalf; M Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Human immunodeficiency virus type 1 gag-protease fusion proteins are enzymatically active.

Authors:  M Kotler; G Arad; S H Hughes
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity.

Authors:  I Katoh; Y Yoshinaka; A Rein; M Shibuya; T Odaka; S Oroszlan
Journal:  Virology       Date:  1985-09       Impact factor: 3.616

9.  An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity.

Authors:  M C Graves; J J Lim; E P Heimer; R A Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

10.  Improved plasmid vectors with a thermoinducible expression and temperature-regulated runaway replication.

Authors:  E Remaut; H Tsao; W Fiers
Journal:  Gene       Date:  1983-04       Impact factor: 3.688

View more
  15 in total

1.  Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.

Authors:  X Wu; H Liu; H Xiao; J A Conway; E Hunter; J C Kappes
Journal:  EMBO J       Date:  1997-08-15       Impact factor: 11.598

2.  A molecular determinant of human immunodeficiency virus particle assembly located in matrix antigen p17.

Authors:  Y Morikawa; T Kishi; W H Zhang; M V Nermut; D J Hockley; I M Jones
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

3.  Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing.

Authors:  G Zybarth; C Carter
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

4.  Specificity and sequence requirements for interactions between various retroviral Gag proteins.

Authors:  E K Franke; H E Yuan; K L Bossolt; S P Goff; J Luban
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

5.  Functional domains of the capsid protein of human immunodeficiency virus type 1.

Authors:  T Dorfman; A Bukovsky; A Ohagen; S Höglund; H G Göttlinger
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.

Authors:  C T Wang; H Y Lai; J J Li
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization.

Authors:  J Colgan; H E Yuan; E K Franke; J Luban
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.

Authors:  J Luban; S P Goff
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription.

Authors:  D Braaten; E K Franke; J Luban
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.

Authors:  N Chazal; C Carrière; B Gay; P Boulanger
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.